🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

6+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 6 of 6 recruiting trials for “Waldenström macroglobulinemia”

Phase 2RecruitingNCT07387471 ↗

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

👨‍⚕️ ABBVIE INC., AbbVie📍 3 sites📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT05099471 ↗

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

👨‍⚕️ Christian Buske, Prof. Dr., University Hospital Ulm Department of Internal Medicine III📍 11 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06561347 ↗

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

👨‍⚕️ Andrew Branagan, MD, PhD, Massachusetts General Hospital📍 5 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT05190705 ↗

Loncastuximab Tesirine in WM

👨‍⚕️ Shayna Sarosiek, MD, Dana-Farber Cancer Institute📍 4 sites📅 Started Feb 2022View details ↗
RecruitingNCT05093153 ↗

Spanish Registry of Patients With IgM Monoclonal Gammopathies

🏥 Fundación Española de Hematología y Hemoterapía📍 51 sites📅 Started Oct 2021View details ↗
Phase 2, PHASE3RecruitingNCT04061512 ↗

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

🏥 University College, London📍 25 sites📅 Started Feb 2020View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →